Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 7 18
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 15 20
BNT162b2 Approved by FDA Experimental Vaccine Jul/11/2022 66 0
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Budesonide Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/31/2021 1 0
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
PCI-27483 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021 1 0
Excel (.xslx) CSV (.csv)